572 related articles for article (PubMed ID: 23500145)
21. Dependence of T cell antigen recognition on T cell receptor-peptide MHC confinement time.
Aleksic M; Dushek O; Zhang H; Shenderov E; Chen JL; Cerundolo V; Coombs D; van der Merwe PA
Immunity; 2010 Feb; 32(2):163-74. PubMed ID: 20137987
[TBL] [Abstract][Full Text] [Related]
22. Critical biological parameters modulate affinity as a determinant of function in T-cell receptor gene-modified T-cells.
Spear TT; Wang Y; Foley KC; Murray DC; Scurti GM; Simms PE; Garrett-Mayer E; Hellman LM; Baker BM; Nishimura MI
Cancer Immunol Immunother; 2017 Nov; 66(11):1411-1424. PubMed ID: 28634816
[TBL] [Abstract][Full Text] [Related]
23. The study of high-affinity TCRs reveals duality in T cell recognition of antigen: specificity and degeneracy.
Donermeyer DL; Weber KS; Kranz DM; Allen PM
J Immunol; 2006 Nov; 177(10):6911-9. PubMed ID: 17082606
[TBL] [Abstract][Full Text] [Related]
24. Stress-testing the relationship between T cell receptor/peptide-MHC affinity and cross-reactivity using peptide velcro.
Gee MH; Sibener LV; Birnbaum ME; Jude KM; Yang X; Fernandes RA; Mendoza JL; Glassman CR; Garcia KC
Proc Natl Acad Sci U S A; 2018 Jul; 115(31):E7369-E7378. PubMed ID: 30021852
[TBL] [Abstract][Full Text] [Related]
25. Avidity characterization of genetically engineered T-cells with novel and established approaches.
Hillerdal V; Boura VF; Björkelund H; Andersson K; Essand M
BMC Immunol; 2016 Jul; 17(1):23. PubMed ID: 27411667
[TBL] [Abstract][Full Text] [Related]
26. Engineering the binding properties of the T cell receptor:peptide:MHC ternary complex that governs T cell activity.
Bowerman NA; Crofts TS; Chlewicki L; Do P; Baker BM; Christopher Garcia K; Kranz DM
Mol Immunol; 2009 Sep; 46(15):3000-8. PubMed ID: 19595460
[TBL] [Abstract][Full Text] [Related]
27. Avidity optimization of a MAGE-A1-specific TCR with somatic hypermutation.
Bassan D; Gozlan YM; Sharbi-Yunger A; Tzehoval E; Greenstein E; Bitan L; Friedman N; Eisenbach L
Eur J Immunol; 2021 Jun; 51(6):1505-1518. PubMed ID: 33835499
[TBL] [Abstract][Full Text] [Related]
28. T-cell receptor triggering is critically dependent on the dimensions of its peptide-MHC ligand.
Choudhuri K; Wiseman D; Brown MH; Gould K; van der Merwe PA
Nature; 2005 Jul; 436(7050):578-82. PubMed ID: 16049493
[TBL] [Abstract][Full Text] [Related]
29. 2D TCR-pMHC-CD8 kinetics determines T-cell responses in a self-antigen-specific TCR system.
Liu B; Zhong S; Malecek K; Johnson LA; Rosenberg SA; Zhu C; Krogsgaard M
Eur J Immunol; 2014 Jan; 44(1):239-50. PubMed ID: 24114747
[TBL] [Abstract][Full Text] [Related]
30. Human cytomegalovirus-specific T-cell receptor engineered for high affinity and soluble expression using mammalian cell display.
Wagner EK; Qerqez AN; Stevens CA; Nguyen AW; Delidakis G; Maynard JA
J Biol Chem; 2019 Apr; 294(15):5790-5804. PubMed ID: 30796163
[TBL] [Abstract][Full Text] [Related]
31. Preclinical Strategies to Identify Off-Target Toxicity of High-Affinity TCRs.
Bijen HM; van der Steen DM; Hagedoorn RS; Wouters AK; Wooldridge L; Falkenburg JHF; Heemskerk MHM
Mol Ther; 2018 May; 26(5):1206-1214. PubMed ID: 29567312
[TBL] [Abstract][Full Text] [Related]
32. T Cell Receptor Engineering and Analysis Using the Yeast Display Platform.
Smith SN; Harris DT; Kranz DM
Methods Mol Biol; 2015; 1319():95-141. PubMed ID: 26060072
[TBL] [Abstract][Full Text] [Related]
33. Key Features Relevant to Select Antigens and TCR From the MHC-Mismatched Repertoire to Treat Cancer.
Audehm S; Glaser M; Pecoraro M; Bräunlein E; Mall S; Klar R; Effenberger M; Albers J; Bianchi HO; Peper J; Yusufi N; Busch DH; Stevanović S; Mann M; Antes I; Krackhardt AM
Front Immunol; 2019; 10():1485. PubMed ID: 31316521
[TBL] [Abstract][Full Text] [Related]
34. Mapping the stochastic sequence of individual ligand-receptor binding events to cellular activation: T cells act on the rare events.
Lin JJY; Low-Nam ST; Alfieri KN; McAffee DB; Fay NC; Groves JT
Sci Signal; 2019 Jan; 12(564):. PubMed ID: 30647147
[TBL] [Abstract][Full Text] [Related]
35. CD8(-) T cell transfectants that express a high affinity T cell receptor exhibit enhanced peptide-dependent activation.
Holler PD; Lim AR; Cho BK; Rund LA; Kranz DM
J Exp Med; 2001 Oct; 194(8):1043-52. PubMed ID: 11602635
[TBL] [Abstract][Full Text] [Related]
36. MHC-restricted fratricide of human lymphocytes expressing survivin-specific transgenic T cell receptors.
Leisegang M; Wilde S; Spranger S; Milosevic S; Frankenberger B; Uckert W; Schendel DJ
J Clin Invest; 2010 Nov; 120(11):3869-77. PubMed ID: 20978348
[TBL] [Abstract][Full Text] [Related]
37. Isolation and characterization of human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells directed toward the widely expressed tumor T-cell epitopes of the telomerase catalytic subunit.
Lev A; Denkberg G; Cohen CJ; Tzukerman M; Skorecki KL; Chames P; Hoogenboom HR; Reiter Y
Cancer Res; 2002 Jun; 62(11):3184-94. PubMed ID: 12036932
[TBL] [Abstract][Full Text] [Related]
38. Specific roles of each TCR hemichain in generating functional chain-centric TCR.
Nakatsugawa M; Yamashita Y; Ochi T; Tanaka S; Chamoto K; Guo T; Butler MO; Hirano N
J Immunol; 2015 Apr; 194(7):3487-500. PubMed ID: 25710913
[TBL] [Abstract][Full Text] [Related]
39. Rapid re-expression of retrovirally introduced versus endogenous TCRs in engineered T cells after antigen-specific stimulation.
van Loenen MM; Hagedoorn RS; de Boer R; van Egmond EH; Falkenburg JH; Heemskerk MH
J Immunother; 2011 Mar; 34(2):165-74. PubMed ID: 21304404
[TBL] [Abstract][Full Text] [Related]
40. Unbiased Identification of T-Cell Receptors Targeting Immunodominant Peptide-MHC Complexes for T-Cell Receptor Immunotherapy.
Lorenz FKM; Ellinger C; Kieback E; Wilde S; Lietz M; Schendel DJ; Uckert W
Hum Gene Ther; 2017 Dec; 28(12):1158-1168. PubMed ID: 28950731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
